Focus Partners Advisor Solutions’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-971
Closed -$563K 1362
2025
Q4
$563K Sell
971
-3,145
-76% -$1.78M 0.01% 680
2025
Q3
$2.04M Buy
4,116
+1,857
+82% +$864K 0.02% 335
2025
Q2
$917K Sell
2,259
-2,828
-56% -$1.18M 0.01% 471
2025
Q1
$2.53M Buy
5,087
+504
+11% +$273K 0.04% 222
2024
Q4
$2.38M Buy
4,583
+2,548
+125% +$1.4M 0.04% 204
2024
Q3
$1.26M Buy
2,035
+290
+17% +$172K 0.03% 258
2024
Q2
$965K Sell
1,745
-2,701
-61% -$1.55M 0.03% 254
2024
Q1
$2.58M Buy
4,446
+3,548
+395% +$1.99M 0.07% 134
2023
Q4
$477K Sell
898
-1
-0.1% -$484 0.02% 259
2023
Q3
$456K Buy
899
+198
+28% +$106K 0.02% 277
2023
Q2
$366K Sell
701
-90
-11% -$48.6K 0.02% 262
2023
Q1
$457K Sell
791
-59
-7% -$33.3K 0.03% 213
2022
Q4
$469K Sell
850
-389
-31% -$206K 0.04% 200
2022
Q3
$628K Buy
1,239
+458
+59% +$256K 0.04% 192
2022
Q2
$424K Buy
781
+272
+53% +$150K 0.04% 207
2022
Q1
$301K Buy
+509
New +$292K 0.03% 240

Other funds holding TMO

Focus Partners Advisor Solutions's TMO Position: Q1 2026 in Review

Focus Partners Advisor Solutions sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 971 shares — an estimated $563K sold.

Focus Partners Advisor Solutions first reported a position in TMO in Q1 2022 and held it in 16 quarters. The position peaked at $2.58M in Q1 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Focus Partners Advisor Solutions reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 971 Thermo Fisher Scientific shares in Q1 2026, an estimated $563K.
  • Focus Partners Advisor Solutions first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 16 quarters.
  • Focus Partners Advisor Solutions's Thermo Fisher Scientific position peaked at $2.58M in Q1 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.